Skip to content
Catalyst

rosuvastatinPapers

Papers about rosuvastatin

papers
651
26 years, by papers

Newest first

351 to 400 of 651

Every paper here, unless its row says otherwiseReturned by a PubMed search for rosuvastatin

  • Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

    Current medical research and opinion2012PMID 22256801

  • One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

    American journal of cardiovascular drugs2012PMID 22263674

  • Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.

    Atherosclerosis2012PMID 22269152

  • Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

    Atherosclerosis2012PMID 22304793

  • Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

    Circulation. Cardiovascular genetics2012PMID 22331829

  • Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.

    Journal of cardiovascular pharmacology and therapeutics2012PMID 22431864

  • The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.

    CMAJ2012PMID 22431901

  • Rosuvastatin improves pulse wave reflection by restoring endothelial function.

    Microvascular research2012PMID 22484031

  • Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

    European heart journal2012PMID 22513778

  • On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

    Journal of the American College of Cardiology2012PMID 22516441

  • Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance.

    Journal of endocrinological investigation2012PMID 22522778

  • Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.

    International journal of occupational and environmental health2012PMID 22550699

  • Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.

    Scottish medical journal2012PMID 22555227

  • Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

    Internal medicine (Tokyo, Japan)2012PMID 22687786

  • The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).

    EuroIntervention2012PMID 22717926

  • Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.

    AIDS (London, England)2012PMID 22739396

  • Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.

    International journal of clinical pharmacology and therapeutics2012PMID 22762855

  • The high-dose rosuvastatin once weekly study (the HD-ROWS).

    Journal of clinical lipidology2012PMID 22836073

  • Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.

    Menopause (New York, N.Y.)2012PMID 22850442

  • Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.

    Chinese medical journal2012PMID 22882843

  • Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

    Journal of the American Society of Echocardiography2012PMID 22884641

  • Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

    Journal of cardiology2012PMID 22884684

  • Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.

    International journal of clinical practice2012PMID 22897461

  • Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.

    The Journal of heart valve disease2012PMID 22953672

  • Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.

    Upsala journal of medical sciences2012PMID 23009223

  • Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.

    Circulation. Cardiovascular genetics2012PMID 23118302

  • The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

    American heart journal2012PMID 23194488

  • Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.

    Journal of clinical lipidology2012PMID 23312049

  • Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.

    International journal of cardiology2011PMID 20085851

  • High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.

    International journal of cardiology2011PMID 20236716

  • Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.

    Journal of viral hepatitis2011PMID 20367801

  • STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D.

    Cardiovascular therapeutics2011PMID 20370794

  • 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.

    International journal of cardiology2011PMID 20471117

  • Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.

    Fundamental & clinical pharmacology2011PMID 20608995

  • Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.

    Clinical research in cardiology2011PMID 20852871

  • Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities.

    European heart journal2011PMID 20971747

  • Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

    Atherosclerosis2011PMID 21056418

  • Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.

    Expert opinion on investigational drugs2011PMID 21114416

  • Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.

    Atherosclerosis2011PMID 21122851

  • Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

    Circulation journal2011PMID 21157106

  • Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.

    Cardiovascular drugs and therapy2011PMID 21174145

  • A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.

    Advances in therapy2011PMID 21222064

  • Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).

    Circulation journal2011PMID 21266787

  • Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

    Cardiovascular ultrasound2011PMID 21299902

  • No effect of rosuvastatin in the zoledronate-induced acute-phase response.

    Calcified tissue international2011PMID 21305270

  • Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.

    Arthritis care & research2011PMID 21309005

  • High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.

    Lipids2011PMID 21327725

  • Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease.

    Clinical biochemistry2011PMID 21349260

  • Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.

    Metabolic syndrome and related disorders2011PMID 21352079

  • Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

    Journal of the American College of Cardiology2011PMID 21492764

The next 50 papers

← Previous 50